Related Experiment Video
Updated: Aug 20, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
The antiapoptotic protein ICBP90 is a target for protein kinase 2
Christian Bronner1, Marie-Aline Trotzier, Odile Filhol
1Institute National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S392, Faculté de Pharmacie, B.P. 60024, 67401 Illkirch, France.
Abstract:
Protein kinase 2 (casein kinase 2 [CK2]) is a protein serine/threonine kinase involved in cell proliferation with an expression that is dysregulated in tumors. ICBP90, a transcription factor exhibiting antiapoptotic properties, has several putative CK2 phosphorylation sites. The aim of the present study was to investigate whether ICBP90 could behave as a CK2 substrate. We observed that ICBP90 was more efficiently phosphorylated by the free CK2a subunit than by the heterotetrameric CK2 (alpha(2), beta(2)). Our results suggest that CK2 is an important regulator of the transcriptional activity of ICBP90 and therefore of the antiapoptotic properties of ICBP90. We propose that the "ICBP90 family" members may be substrates for CK2.
Insights
Casein kinase 2 (CK2) phosphorylates the transcription factor ICBP90, regulating its antiapoptotic properties. This suggests CK2 influences cell proliferation and may be a therapeutic target in tumors expressing ICBP90.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Casein kinase 2 (CK2) is a serine/threonine kinase crucial for cell proliferation.
- CK2 expression is frequently dysregulated in various tumors.
- ICBP90 is a transcription factor with antiapoptotic functions and potential CK2 phosphorylation sites.
Purpose of the Study:
- To investigate if ICBP90 serves as a substrate for CK2.
- To elucidate the regulatory role of CK2 in ICBP90's transcriptional activity and antiapoptotic functions.
Main Methods:
- In vitro kinase assays using purified CK2 subunits and recombinant ICBP90.
- Analysis of ICBP90 phosphorylation by free CK2 alpha subunit versus heterotetrameric CK2.
Main Results:
- ICBP90 is phosphorylated by CK2.
- Phosphorylation is more efficient with the free CK2 alpha subunit compared to the heterotetrameric form.
- CK2 activity is suggested to regulate ICBP90's transcriptional activity and antiapoptotic properties.
Conclusions:
- CK2 acts as a regulator of ICBP90's transcriptional activity.
- CK2-mediated phosphorylation of ICBP90 influences its antiapoptotic properties.
- Members of the ICBP90 family may be substrates for CK2, indicating a broader role in cellular regulation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway
Anaphase Promoting Complex
The JAK-STAT Signaling Pathway
Caspases
